UBS names its winners and losers of next month's earnings season

If you want to gain an edge over the market, you will need to be able to pick companies that are likely to beat and miss market expectations. UBS is offering you a few hints.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are heading into one of the most exciting times of the year as ASX-listed companies gear up to hand in earnings report cards and outlook statements next month.

We will soon learn who has been swimming naked!

If you are looking to gain an edge over the market, knowing which company is likely to beat or miss market expectations will be key.

While experts are expecting a decent set of results, there is really nothing to get excited about with the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) trading on a price-earnings (P/E) multiple of around 15 times and consensus tipping 7% earnings per share (EPS) growth – both more or less in-line with the longer-term average.

The forecast growth pales in comparison to offshore markets with UBS noting that the rest of the world is expected to deliver EPS growth of 10% this calendar year after generating 14% growth in 2017.

What's more, growth sectors (such as healthcare) are trading well above their 10 or 20-year average multiples.

"With 'growth' rallying globally during the last (August) reporting period, the market shrugged off some underwhelming results," said UBS.

"But with multiples higher and macro conditions turning against 'growth' somewhat, the market may not be as forgiving in February."

The sector that the broker believes will see most of the earnings upgrades is resources thanks to the stronger for longer spot commodity prices.

Outside of resources, consensus earnings estimates are still being pared back, although at a benign pace of around 2% over the past six months, which is pretty much the norm.

Some large caps that the broker expects will deliver results ahead of market expectations include:

  • Ansell Limited (ASX: ANN): the glove maker could deliver an upside surprise through its cost-out program and improving global macro conditions.
  • Harvey Norman Holdings Limited (ASX: HVN): The furniture and electrical retailer is likely to beat consensus thanks to strength in household goods. Management may also surprise by announcing some capital management initiative, such as a share buyback.
  • Qantas Airways Limited (ASX: QAN): The airline operator has enjoyed strong loads and yields, which could drive earnings ahead of what the market is expecting. UBS also believes management will announce a capital management initiative that may be a combination of dividends and buybacks.

On the flipside, blue-chips that are most at risk of posting results below market expectations include:

  • Lendlease Group (ASX: LLC): The property and construction group had flagged issues on some construction projects and will likely provide further details that could disappoint the market, although quite a bit of bad news appears to be factored into its current share price.
  • Primary Health Care Limited (ASX: PRY): The medical services group may announce further costs from its restructuring as new management clears the deck.
  • Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC): The hospital operator is at risk of delivering disappointing growth for its Australian operations and new management may also be tempted to deliver bad news to rebase expectations.

Looking for other blue-chip stock ideas for 2018? The experts at the Motley Fool have uncovered three that they think are well placed to outperform this year, if not beyond.

Click on the link below to find out for free what these stocks are.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »